A Phase I trial to investigate the effect of nintedanib on the pharmacokinetics of a combination of ethinylestradiol and levonorgestrel in female patients with Systemic Sclerosis associated Interstitial Lung Disease (SSc-ILD) (1199-0340) First published 12/03/2021 Last updated 23/04/2024 EU PAS number:EUPAS40026 Study Finalised